APAbhishek Pandey

Abhishek Pandey

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Abhishek Pandey has a total of 50 co-authors. Here are the top co-authors by number of shared publications:

  • Girardin Jean-Louis

    Department of Psychiatry and Behavioral Sciences, University of Miami Miller School of Medicine, Miami, USA

    11 shared publications
  • G. Ogedegbe

    Center for Healthful Behavior Change

    3 shared publications
  • M. Demede

    Division of Cardiovascular Medicine, Department of Medicine SUNY Downstate Medical Center, 450 Clarkson Avenue, Brooklyn, NY 11203-2098, USA

    3 shared publications
  • S. I. McFarlane

    Division of Endocrinology, Diabetes, and Hypertension

    3 shared publications
  • F. Zizi

    Brooklyn Center for Health Disparities, Department of Medicine, SUNY Downstate Medical Center, 450 Clarkson Avenue, P.O. Box 1199, Brooklyn, NY 11203-2098, USA

    2 shared publications
  • Ferdinand Zizi

    Brooklyn Health Disparities Center, Department of Medicine, SUNY Downstate Medical Center, NY

    2 shared publications

Latest Publications

  • Open Access

    Associations between inadequate sleep and obesity in the US adult population: analysis of the national health interview survey (1977–2009)

    by Girardin Jean-Louis, Natasha J Williams, Daniel Sarpong, Abhishek Pandey, Shawn Youngstedt, Ferdinand Zizi, Gbenga Ogedegbe

    Epidemiologic studies show a curvilinear relationship between inadequate sleep (< 7 or > 8 hours) and obesity (Body Mass Index > 30 kg/m2), which have enormous public health impact.


  • Open Access

    Excessive daytime sleepiness and adherence to antihypertensive medications among Blacks: analysis of the counseling African Americans to control hypertension (CAATCH) trial

    by Natasha J Williams, Girardin Jean-Louis, Abhishek Pandey, Joseph Ravenell, Carla Boutin-Foster, Gbenga Ogedegbe

    Background: Excessive daytime sleepiness (EDS) often occurs as a result of insufficient sleep, sleep apnea, illicit substance use, and other medical and psychiatric conditions. This study tested the hypothesis that blacks exhibiting EDS would have poorer self-reported adherence to hypertensive medication using cross-sectional data from the Counseling African-Americans to Control Hypertension (CAATCH) trial. Methods: A total of 1,058 hypertensive blacks (average age 57±12 years) participated in CAATCH, a randomized controlled trial evaluating the effectiveness of a multilevel intervention for participants who receive care from community health centers in New York City. Data analyzed in this study included baseline sociodemographics, medical history, EDS, and medication adherence. We used the Epworth Sleepiness Scale, with a cutoff score of ≥10, to define EDS. Medication adherence was measured using an abbreviated Morisky Medication Adherence scale, with a score >0 indicating nonadherence. Results: Of the sample, 71% were female, 72% received at least a high school education, 51% reported a history of smoking, and 33% had a history of alcohol consumption. Overall, 27% of the participants exhibited EDS, and 44% of those who exhibited EDS were classified as adherent to prescribed antihypertensive medications. Multivariable logistic regression analysis, adjusting for effects of age, body mass index, sex, education, and smoking and drinking history indicated that participants who exhibited EDS were more than twice as likely to be nonadherent (odds ratio 2.28, 95% confidence interval 1.42–3.67, PConclusion: Analysis of the CAATCH data showed a high prevalence of EDS among hypertensive blacks. EDS is a significant predictor of nonadherence to prescribed medications for hypertension. These findings point to a modifiable variable that can be targeted in future interventions focusing on medication adherence.


  • Sleep in America: Role of racial/ethnic differences

    by Bosede Adenekan, Abhishek Pandey, Sharon McKenzie, Ferdinand Zizi, Georges J. Casimir, Girardin Jean-Louis


  • Extreme Sleep Durations and Increased C-Reactive Protein: Effects of Sex and Ethnoracial Group

    by Michael A. Grandner, Orfeu M. Buxton, Nicholas Jackson, Megan Sands-Lincoln, Abhishek Pandey, Girardin Jean-Louis

    S and full research articles published in SLEEP, the official journal of the APSS. Sleep and sleep disorder scientific findings.


  • Open Access

    Linking Sleep to Hypertension: Greater Risk for Blacks

    by A. Pandey, N. Williams, M. Donat, M. Ceide, P. Brimah, G. Ogedegbe, S. I. McFarlane, G. Jean-Louis

    Background. Evidence suggests that insufficient sleep duration is associated with an increased likelihood for hypertension. Both short (8 hour) sleep durations as well as hypertension are more prevalent among blacks than among whites. This study examined associations between sleep duration and hypertension, considering differential effects of race and ethnicity among black and white Americans.Methods. Data came from a cross-sectional household interview with 25,352 Americans (age range: 18–85 years).Results. Both white and black short sleepers had a greater likelihood of reporting hypertension than those who reported sleeping 6 to 8 hours. Unadjusted logistic regression analysis exploring the race/ethnicity interactions between insufficient sleep and hypertension indicated that black short (8 hours) sleepers were more likely to report hypertension than their white counterparts (OR = 1.34 and 1.37, resp.;P<0.01). Significant interactions of insufficient sleep with race/ethnicity were observed even after adjusting to effects of age, sex, income, education, body mass index, alcohol use, smoking, emotional distress, diabetes, coronary heart disease, and stroke.Conclusion. Results suggest that the race/ethnicity interaction is a significant mediator in the relationship between insufficient sleep and likelihood of having a diagnosis of hypertension.


  • Obesity, Diabetes, the Cardiorenal Syndrome, and Risk for Cancer

    by Victoria Forte, Abhishek Pandey, Rita Abdelmessih, Giovanna Forte, Adam Whaley-Connell, James R. Sowers, Samy I. McFarlane

    Numerous epidemiological studies confirm that the prevalence of obesity and the cardiorenal metabolic syndrome (CRS) is extraordinarily high and that the rates have increased dramatically in the last three decades. In addition, epidemiological data demonstrate that obesity, the CRS, and diabetes are inextricably linked and are all associated with an increased incidence of a number of solid tissue cancers. The mechanisms for this association have been examined, including, but not limited to, higher levels of insulin and free levels of insulin-like growth factor and insulin resistance in obesity and the CRS. Mortality, morbidity, and the associated health care costs which are the link between obesity, the CRS, and diabetes are just beginning to be examined. In addition, we review the advantages of implementing lifestyle and surgical changes to modify obesity, lessening the development of the CRS, diabetes, and associated cancers. Epidemiological data regarding the general mechanisms of the pathogenesis of cancers associated with obesity, the CRS, and diabetes (specifically colon, pancreas, esophageal, liver, breast, prostate, thyroid, and renal carcinomas) are reviewed. The mechanisms by which obesity and other components of the CRS contribute to the pathogenesis of these cancers, such as hormone alterations and insulin- and insulin-like growth factor-dependent pathways of tumor pathogenesis, include the attending roles of inflammation and oxidative stress. Emphasis has been placed on obesity as a modifiable risk factor which, when addressed, provides a reduction in the rate of cancer deaths. In a second part to be published in the next issue of this journal, the relationship between diabetes and cancer will be reviewed in detail.


  • Race/Ethnicity, Sleep Duration, and Diabetes Mellitus: Analysis of the National Health Interview Survey

    by Ferdinand Zizi, Abhishek Pandey, Renee Murrray-Bachmann, Miriam Vincent, Samy McFarlane, Gbenga Ogedegbe, Girardin Jean-Louis


  • T-O-129 RACE/ETHNICITY, SLEEP DURATION, AND QUALITY OF LIFE: ANALYSIS OF THE BEHAVIORAL RISK FACTOR SURVEILLANCE SYSTEM

    by Abhishek Pandey, Melaku Demede, Felicia McKoy, Ferdinand Zizi, Girardin Jean-Louis

  • T-I-071 SHORT SLEEP AND DYSFUNCTIONAL BELIEFS AND ATTITUDES TOWARD SLEEP AMONG BLACK MEN

    by Abhishek Pandey, Dmitriy Gekhman, Prince Odigie, Girardin Jean-Louis

    • 1 September 2011
      • Vol. 36  (3) , 187-209

    Diabetes mellitus and the risk of cancer

    by A. Pandey, V. Forte, M. Abdallah, A. Alickaj, S. Mahmud, S. Asad, S. I. McFarlane

    Although diabetes has been known to increase the risk of cancer for over a century, it was not until recently when this area gained momentum and generated a lot of interest. That is in- part because of the rising global diabetes epidemic and the wide spread use of insulin analogues, metformin and other anti-diabetic agents, providing hypothesis generating data on the cancer risk in the diabetic population. Type 2 diabetes is associated with increased risk of breast, colon, pancreatic and other types of cancer, while type 1 diabetes is associated with increase in stomach, pancreatic, endometrial and cervical cancer. Mechanisms postulated for increased cancer risk in diabetes include hyperglycemia, hyperinsulinemia with stimulation of IGF-1 axis, obesity that serves as a common soil hypothesis for both cancer and diabetes as well as other factors such as increased cytokine production. More recently some antidiabetic agents have been thought to increase cancer risk such as insulin glargine, while metformin appears to lower cancer risk. In this review, we present the evidence for the link between diabetes and cancer highlighting the general mechanisms proposed for such a link as well as specific hypotheses for individual cancer. We will also discuss the role of insulin, metformin and other antidiabetic agents in cancer risk.